Thomas Schnettler - Managing Director @ Piper Jaffray Merchant Banking - Crunchbase Person Profile

Start Free Trial

Overview

Number of Portfolio Companies

Number of Exits

Unlock for free

Primary Job Title Managing Director
Primary Organization
Piper Jaffray Merchant Banking

Location Minneapolis, Minnesota, United States
Regions Greater Minneapolis-Saint Paul Area, Great Lakes, Midwestern US
Gender Male

Investor Type
obfuscated
obfuscation
Number of Exits
obfuscated
obfuscation

LinkedIn View on LinkedIn

Thomas Schnettler, is serves as Managing Director of Piper Jaffray Merchant Banking. He attended Harvard Law School.

Personal Investments

Number of Investments

Thomas Schnettler

invested in

Akoya Biosciences

on

obfuscation

. This investment -

Series D - Akoya Biosciences

- was valued at

obfuscation

.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Akoya Biosciences	—	Series D - Akoya Biosciences	obfuscated obfuscation

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Elligo Health Research	Piper Jaffray Merchant Banking	Yes	Series C - Elligo Health Research	obfuscated obfuscation

Exits

Number of Exits

Unlock for free

Thomas Schnettler

has

obfuscation

exit -

Akoya Biosciences

.

Thomas Schnettler

has

obfuscation

exits. Their most notable exits are

Akoya Biosciences

.

Akoya Biosciences Akoya Biosciences is a spatial biology company offering solutions for high-parameter tissue analysis from biomarker discovery to validation.

Jobs

Number of Current Jobs

Thomas Schnettler

is the

Managing Director

at

Piper Jaffray Merchant Banking

.

Piper Jaffray Merchant Banking Managing Director

Related Hubs

Hub Name	CB Rank (Hub)
Private Equity Stage Investors with Investments in Minnesota	54,864
Private Equity Firms with Investments in Midwestern US	13,269
Great Lakes Private Equity Stage Investors	26,552
Midwestern US Investors with Funds Raised in 2018	80,063
Greater Minneapolis-Saint Paul Area Private Equity Stage Investors	79,041
Private Equity Firms with Investments in Minnesota	71,363
Private Equity Firms with Investments in Minneapolis, Minnesota	66,504
Investors Active in Greater Minneapolis-Saint Paul Area	16,290
Minnesota Private Equity Firms	44,963
Minneapolis Investors	34,221

Recent News and Activity

Funding Round•

Dec 5, 2019

Akoya Biosciences raised

obfuscation

from Innovatus Capital Partners and 3 other investors

Discover more funding rounds